Skip to main content

Karyopharm Therapeutics widens losses

Karyopharm Therapeutics Inc. (Nasdaq: KPTI) widened second quarter losses to 92 cents per share from 55 cents per share in the year ago period. Shares of the pharmaceutical firm plummeted $8.61 to close at $13.44.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.